SEVERNA PARK, Md.--(BUSINESS WIRE)--iSonea Ltd. (ASX:ISN);(OTCQX:ISOAY), an emerging medical technology company developing innovative monitoring systems and software for the management of asthma, today announced that Viriathus Research LLC has issued an initial informational research report on the Company. iSonea’s American Depositary Receipts (ADRs) began trading today on the OTCQX marketplace in the U.S. under the symbol ISOAY.
